News flow
@OrexoABpubl
12 April 2021
THIS IS BEYOND. Such an inspiring and hopeful story our colleague PSyD Gery-Lynn Utter brings to her important work… https://t.co/LqjD2va8er
@OrexoABpubl
8 April 2021
To avoid being captured in the vicious circle of #addiction there is a need of counselling support to cope with AUD… https://t.co/wcpUZLvlap
@OrexoABpubl
7 April 2021
Ethypharm acquires the rights to deprexis & vorvida in 4 European countries from our partner @GAIA_COM. Yet another… https://t.co/USDN34EMMN
Europe |
US |
 |
|
|
Lena Wange IR & Corporate Communications Director Switchboard: +46 (0)18 780 88 00 Direct phone: +48 73 064 16 36 Send email: ir@orexo.com Location: Uppsala, Sweden |
Dennis Urbaniak EVP Digital Therapeutics Switchboard: +1 (0)855 982 7658 Direct phone: +1 973 294 3183 Send email: us.media@orexo.com Location: New Jersey, US |
